Cholinergic Receptor Nicotinic Alpha Subunit 4 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
CHRNA4 encodes the alpha 4 subunit of the nicotinic acetylcholine receptor, a ligand-gated ion channel that mediates fast synaptic transmission. The α4β2 nicotinic receptor is the most abundant nicotinic receptor in the brain and is critical for cognitive function, attention, and reward processing. CHRNA4 mutations cause autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE). The receptor is a therapeutic target for smoking cessation and cognitive enhancement.
| Property |
Value |
| Gene Symbol |
CHRNA4 |
| Full Name |
Cholinergic Receptor Nicotinic Alpha Subunit 4 |
| Chromosomal Location |
20q13.31 |
| NCBI Gene ID |
1137 |
| OMIM |
118504 |
| Ensembl ID |
ENSG00001202073 |
| UniProt ID |
P43681 |
Nicotinic α4β2 receptor function:
- Ion channel: Permits Na+ and Ca2+ influx
- Cognitive enhancement: Attention, working memory
- Reward processing: Mesolimbic dopamine modulation
- Wide distribution: Cortex, hippocampus, thalamus
- ADNFLE: CHRNA4 mutations cause nocturnal seizures
- Smoking behavior: Nicotine addiction pathways
- Cognitive decline: Alzheimer's disease vulnerability
- Smoking cessation: Varenicline targets α4β2
- Cognitive enhancement: Nicotinic agonists
- ADNFLE: Antiepileptic strategies
The study of Cholinergic Receptor Nicotinic Alpha Subunit 4 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Picciotto MR, et al. (2015). Nicotinic acetylcholine receptors and disease. Pharmacol Rev. 67(4):887-904. PMID:26419448
The nicotinic acetylcholine receptor (nAChR) is a pentameric ligand-gated ion channel:
- Alpha subunits: Binding sites for acetylcholine
- Beta subunits: Modulatory subunits
- Stoichiometry: Typically (α4)₂(β2)₃ in brain
- ** transmembrane domains**: Five subunits arrange around central pore
- α4β2: Most abundant in brain, high affinity for nicotine
- α4β4: Higher sensitivity, found in peripheral nervous system
- α4-containing: Include α4β2, α4β4, α4δ, α4γ
CHRNA4 shows region-specific expression:
- Hippocampus: High expression in CA1-CA3 regions
- Cortex: Layer 5 pyramidal neurons
- Thalamus: Relay neurons
- Basal ganglia: Striatal interneurons
- Substantia nigra: Pars compacta dopaminergic neurons
- ACh binding induces conformational change
- Channel pore opens within microseconds
- Na⁺ and Ca²⁺ influx depolarizes membrane
- Rapid desensitization follows activation
- cAMP/PKA: Modulated by PKA phosphorylation
- MAPK/ERK: Downstream signaling cascade
- Calcium signaling: Ca²⁺ influx activates calmodulin
- ↓ α4β2 receptor density in AD cortex
- Correlates with cognitive decline
- Nicotinic agonists show cognitive benefit
- Connection to cholinergic hypothesis
- Loss of α4β2 in substantia nigra
- Nicotine may provide neuroprotection
- Smoking paradox (protective but harmful)
- Attention and working memory
- Spatial memory formation
- Executive function
- CHRNA4 knockout mice: Show cognitive deficits
- Transgenic models: Overexpression studies
- Humanized mice: Express human CHRNA4
- Onset: Childhood to adolescence
- Seizure type: Nocturnal focal seizures
- Mutation types: Point mutations in M1-M4 domains
- Varenicline (Chantix): Partial agonist at α4β2
- Cytisine: Agonist used in smoking cessation
- ABT-594: Experimental cognitive enhancer